These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10826957)

  • 1. Catalytic mechanism of an abzyme displaying a beta-lactamase-like activity.
    Avalle B; Débat H; Friboulet A; Thomas D
    Appl Biochem Biotechnol; 2000; 83(1-3):163-9; discussion 169-71, 297-313. PubMed ID: 10826957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of inhibitory monoclonal antibodies. A critical step for producing anti-idiotypic catalytic antibodies.
    Avalle B; Friboulet A; Thomas D
    Ann N Y Acad Sci; 1998 Dec; 864():118-30. PubMed ID: 9928086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional mimicry: elicitation of a monoclonal anti-idiotypic antibody hydrolizing beta-lactams.
    Avalle B; Thomas D; Friboulet A
    FASEB J; 1998 Aug; 12(11):1055-60. PubMed ID: 9707178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a functional scFv fragment of an anti-idiotypic antibody with a beta-lactam hydrolytic activity.
    Padiolleau-Lefèvre S; Débat H; Phichith D; Thomas D; Friboulet A; Avalle B
    Immunol Lett; 2006 Feb; 103(1):39-44. PubMed ID: 16325271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal catalytic anti-idiotypic antibodies with a beta-lactamase activity.
    Avalle B; Mistro D; Thomas D; Friboulet A
    Ann N Y Acad Sci; 1996 Oct; 799():172-5. PubMed ID: 8958088
    [No Abstract]   [Full Text] [Related]  

  • 6. Overpassing an aberrant V(kappa) gene to sequence an anti-idiotypic abzyme with (beta)-lactamase-like activity that could have a linkage with autoimmune diseases.
    Debat H; Avalle B; Chose O; Sarde CO; Friboulet A; Thomas D
    FASEB J; 2001 Mar; 15(3):815-22. PubMed ID: 11259400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalysis by anti-idiotypic antibodies.
    Avalle B; Friboulet A; Thomas D
    Chem Immunol; 2000; 77():80-8. PubMed ID: 11706707
    [No Abstract]   [Full Text] [Related]  

  • 8. Selection of peptides inhibiting a beta-lactamase-like activity.
    Yribarren AS; Thomas D; Friboulet A; Avalle B
    Eur J Biochem; 2003 Jul; 270(13):2789-95. PubMed ID: 12823549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A suicide-substrate mechanism for hydrolysis of beta-lactams by an anti-idiotypic catalytic antibody.
    Lefevre S; Debat H; Thomas D; Friboulet A; Avalle B
    FEBS Lett; 2001 Jan; 489(1):25-8. PubMed ID: 11231007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiidiotypic antibodies exhibiting an acetylcholinesterase abzyme activity.
    Joron L; Izadyar L; Friboulet A; Remy MH; Pancino G; Roseto A; Thomas D
    Ann N Y Acad Sci; 1992 Nov; 672():216-23. PubMed ID: 1476371
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiotypic mimicry of a catalytic antibody active site.
    Johnson G; Moore SW
    Mol Immunol; 2002 Oct; 39(5-6):273-88. PubMed ID: 12220886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and inhibition studies of Bacillus cereus beta-lactamase using a spectrophotometric method.
    Münch R; Wombacher H; Körber F
    J Clin Chem Clin Biochem; 1981 Sep; 19(9):953-60. PubMed ID: 6793687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitarget selection of catalytic antibodies with β-lactamase activity using phage display.
    Shahsavarian MA; Chaaya N; Costa N; Boquet D; Atkinson A; Offmann B; Kaveri SV; Lacroix-Desmazes S; Friboulet A; Avalle B; Padiolleau-Lefèvre S
    FEBS J; 2017 Feb; 284(4):634-653. PubMed ID: 28075071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the interactions between beta-lactams and a metallo-beta-lactamase from bacillus cereus using a monoclonal antibody.
    Chambers SJ; Wyatt GM; Morgan MR
    Anal Biochem; 2001 Jan; 288(2):149-55. PubMed ID: 11152585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic antibodies with acetylcholinesterase activity.
    Johnson G; Moore SW
    J Immunol Methods; 2002 Nov; 269(1-2):13-28. PubMed ID: 12379349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient refolding of a recombinant abzyme : structural and catalytic characterizations.
    Ben Naya R; Matti K; Guellier A; Matagne A; Boquet D; Thomas D; Friboulet A; Avalle B; Padiolleau-Lefèvre S
    Appl Microbiol Biotechnol; 2013 Sep; 97(17):7721-31. PubMed ID: 23250220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and application of antibodies modifying the function of beta-lactamase.
    Bibi E; Laskov R
    Biochim Biophys Acta; 1990 Aug; 1035(2):237-41. PubMed ID: 2118387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active sites of beta-lactamases from Bacillus cereus.
    Hill HA; Sammes PG; Waley SG
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):333-44. PubMed ID: 6109328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of beta-lactamases I and II from Bacillus cereus with semisynthetic cephamycins. Kinetic studies.
    Martin Villacorta J; Arriaga P; Laynez J; Menendez M
    Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):111-4. PubMed ID: 1930129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.